Key facts
- It has raised $37.4M across 1 recorded rounds; the latest was Early Stage VC ($20.9M) in Jun 2025.
- Notable investors include Cardinal Health, Carrier Ventures, Mike Pompeo, Sea Court Capital.
- Ember LifeSciences has filed 1 Form D with the SEC, most recently Mar 2026 ($20.9M sold to 38 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Ember LifeSciences
Funding rounds
1 roundsAbout Ember LifeSciences
Manufacturer of refrigerated shipping box intended to revolutionise the way people eat, drink and live. The company's product allows temperature-sensitive medicines to arrive at the required temperature range and be ready for use and the cloud connectivity allows for live tracking of the shipment location, enabling businesses to reduce millions of pounds of waste produced each year of packing materials for pharmaceuticals.
- Sector
- Information Technology
- HQ
- Westlake Village, CA, United States
- Founded
- 2022
- Employees
- 24
- Website
- emberlifesciences.com/
- Ownership
- Privately Held (backing)
Ember LifeSciences doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ember LifeSciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ember LifeSciences in its N-PORT filings yet. We sweep new filings monthly.